RHODOS Follow-up Single-visit Study

Completed

• Conditions: Leber's Hereditary Optic Neuropathy

• Registration Number: NCT01421381
• Lead Sponsor: Santhera Pharmaceuticals

Brief Summary

This study aims to evaluate the current visual acuity of SNT-II-003 participants and compare this with the last visit from the SNT-II-003 study.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2011-08-19
• Study First Submitted QC: 2011-08-19
• Study First Posted: 2011-08-22
• Study Start: 2011-09
• Primary Completion: 2011-11
• Study Completion: 2011-12
• Status Verified: 2013-05
• Last Update Submitted: 2013-05-24
• Last Update Posted: 2013-05-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Previous participation in study SNT-II-003

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
logMAR visual acuity	measure taken at the single study visit (Week 24)	Change in best logMAR visual acuity (Best Acuity) compared to Visit 2/Baseline and Visit 5/Week 24 or last treatment visit of SNT-II-003

Trial Locations

Locations (3)

Biomedical Research Centre, The Medical School; 🇬🇧 Newcastle upon Tyne, United Kingdom

Friedrich Baur Institut Neurologische Klinik und Poliklinik; 🇩🇪 München, Germany

Hôpital Notre-Dame (CHUM); 🇨🇦 Montreal,, Quebec, Canada